Ranbaxy Laboratories rose 3.37% to Rs 321.95 at 12:57 IST on BSE after the company received a final approval from the US drug regulator for a generic drug.
Online Index DAILY Chart & Swing trading Page
Online Index DAILY Chart & Swing trading Page
Ranbaxy Laboratories rose 3.37% to Rs 321.95 at 12:57 IST on BSE after the company received a final approval from the US drug regulator for a generic drug.